So Kent Chak-Yu, Yap Jonathan, Song Guang-Yuan, Poon Karl, Sung Shih-Hsien, Chandavimol Mann, Hayashida Kentaro, Park Duk-Woo, Ewe See-Hooi, Chen Mi, Hei-Tung Chan Vyanne, Iwata Juri, Tangcharoen Tarinee, Tern Paul, Park Han-Su, Alasnag Mirvat, Ohno Yohei, Hon Jimmy Kim Fatt, Bhagwandeen Rohan, Tabata Minoru, Lee Alex Pui-Wai, Jilaihawi Hasan, Wang Dee Dee, Tang Gilbert H L, Lim D Scott, Modine Thomas, Lam Yat-Yin
Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, HKSAR, China.
Department of Cardiology, National Heart Centre Singapore, Singapore; Duke-NUS Medical School, Singapore. Electronic address: https://twitter.com/Jonyap88.
JACC Asia. 2025 May 3;5(6):718-43. doi: 10.1016/j.jacasi.2025.03.011.
Valvular heart disease poses a significant health burden in the Asia-Pacific region, with its epidemiology varying widely across countries caused by diverse socioeconomic and health care situations. Rheumatic heart disease remains prevalent, especially in low- to middle-income areas, while degenerative valvular diseases are emerging in developed regions caused by an aging population. Significant disparities in access to health care and intervention result in variable clinical outcomes. In the past decade, transcatheter interventions have revolutionized the management of patients with valvular heart disease globally. In the Asia-Pacific region, the uptake and development of transcatheter valvular interventions has been slow until recent years. Continued collaboration across the Asia-Pacific region is essential to mitigate the impact of the upcoming surge of valvular heart disease in this diverse and rapidly changing area.
心脏瓣膜病在亚太地区造成了沉重的健康负担,由于社会经济和医疗保健情况各异,其流行病学在各国之间差异很大。风湿性心脏病仍然普遍存在,尤其是在低收入和中等收入地区,而在发达地区,由于人口老龄化,退行性瓣膜病正在出现。在获得医疗保健和干预措施方面存在显著差异,导致临床结果各不相同。在过去十年中,经导管干预彻底改变了全球心脏瓣膜病患者的治疗方式。在亚太地区,直到近年来,经导管瓣膜干预的应用和发展一直很缓慢。在这个多样化且迅速变化的地区,亚太地区持续开展合作对于减轻即将到来的心脏瓣膜病激增的影响至关重要。
JACC Asia. 2025-5-3
Hum Vaccin Immunother. 2024-12-31
Clin Mol Hepatol. 2025-7
Osteoporos Sarcopenia. 2025-6
JACC Cardiovasc Interv. 2024-12-9
JACC Cardiovasc Interv. 2024-7-8
JACC Cardiovasc Imaging. 2025-1
Nat Rev Cardiol. 2024-10